Two Sigma Investments, LP Uni Qure N.V. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Two Sigma Investments, LP holds 804,896 shares of QURE stock, worth $4.59 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

804,896

Previous 119,276 574.82%

Holding current value

$4.59 Million

Previous $534,000 643.07%

% of portfolio

0.01%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.78 - $10.12 $2.59 Million - $6.94 Million	685,620 Added 574.82%	804,896 $3.97 Million
Q2 2024 Aug 14, 2024	SELL	$4.39 - $5.43 $513,634 - $635,315	-117,001 Reduced 49.52%	119,276 $534,000
Q1 2024 May 15, 2024	BUY	$4.82 - $6.93 $550,930 - $792,105	114,301 Added 93.71%	236,277 $1.23 Million
Q4 2023 Feb 14, 2024	BUY	$5.63 - $8.27 $341,273 - $501,302	60,617 Added 98.79%	121,976 $825,000
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $1.81 Million - $3.19 Million	-270,023 Reduced 81.48%	61,359 $411,000
Q2 2023 Aug 14, 2023	BUY	$11.12 - $22.2 $790,932 - $1.58 Million	71,127 Added 27.33%	331,382 $3.8 Million
Q1 2023 May 15, 2023	SELL	$18.7 - $23.07 $113,826 - $140,427	-6,087 Reduced 2.29%	260,255 $5.24 Million
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $3.5 Million - $5.27 Million	192,944 Added 262.87%	266,342 $6.04 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $1.25 Million - $1.87 Million	73,398 New	73,398 $1.38 Million
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $1.92 Million - $3.42 Million	-94,855 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $2.47 Million - $3.63 Million	94,855 New	94,855 $3.04 Million
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $4.74 Million - $5.88 Million	-158,096 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$29.24 - $42.03 $2.69 Million - $3.86 Million	91,930 Added 138.94%	158,096 $5.33 Million
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $2.05 Million - $2.94 Million	-57,972 Reduced 46.7%	66,166 $2.39 Million
Q3 2020 Nov 16, 2020	BUY	$35.98 - $47.66 $4.47 Million - $5.92 Million	124,138 New	124,138 $4.57 Million
Q1 2020 May 15, 2020	SELL	$40.01 - $73.97 $1.15 Million - $2.13 Million	-28,745 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$37.13 - $74.62 $14.9 Million - $30 Million	-402,134 Reduced 93.33%	28,745 $2.06 Million
Q3 2019 Nov 14, 2019	BUY	$39.36 - $76.8 $16.6 Million - $32.5 Million	422,779 Added 5219.49%	430,879 $17 Million
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $2.48 Million - $3.87 Million	-47,080 Reduced 85.32%	8,100 $633,000
Q1 2019 May 15, 2019	BUY	$27.39 - $68.41 $1.09 Million - $2.73 Million	39,858 Added 260.14%	55,180 $3.29 Million
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $210,466 - $313,207	9,231 Added 151.55%	15,322 $442,000
Q3 2018 Nov 14, 2018	BUY	$29.75 - $43.08 $181,207 - $262,400	6,091 New	6,091 $222,000
Q1 2018 May 15, 2018	SELL	$17.1 - $26.61 $2.38 Million - $3.7 Million	-138,891 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$9.47 - $19.59 $1.32 Million - $2.72 Million	138,891	138,891 $2.72 Million

Others Institutions Holding QURE

# of Institutions

153

Shares Held

41M

Call Options Held

925K

Put Options Held

617K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $266M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Uni Qure N.V. Transaction History